International Journal of Pharma Growth Research Review

About the Journal (View Full Page)

International Journal of Pharma Growth Research Review (IJPGARR) is an international, open-access, peer-reviewed academic journal dedicated to publishing high-quality research in pharmaceutical sciences, drug development, and healthcare innovations. The journal provides a global scholarly platform for researchers, academicians, scientists, pharmacists, and industry professionals to disseminate original research, review articles, and empirical studies that advance pharmaceutical growth, drug safety, therapeutic innovations, and healthcare solutions at local, national, and global levels.

Open Access Policy

IJPGARR is a fully open-access journal, ensuring that all published articles are freely accessible to readers worldwide without subscription or access fees. In accordance with the Budapest Open Access Initiative (BOAI), users are allowed to read, download, copy, distribute, print, search, or link to the full texts of articles, and use them for any lawful purpose, without prior permission from the publisher or authors.

Open Access License

To support the widest possible dissemination of research, all articles published in IJPGARR are licensed under the Creative Commons Attribution License 4.0 (CC BY 4.0).

1. Share: Copy and redistribute the material in any medium or format
2. Adapt: Remix, transform, and build upon the material for any purpose, including commercial use
3. Copyright: Authors retain full copyright and publishing rights without restrictions

Aims and Scope (View Full Page)

IJPGARR invites original research articles, review papers, and case studies in pharmaceutical sciences, drug research, and allied multidisciplinary fields, including but not limited to:

1. Pharmaceutical Research & Development: Drug discovery, formulation development, and novel drug delivery systems.
2. Pharmacology & Therapeutics: Clinical pharmacology, pharmacokinetics, pharmacodynamics, and therapeutic innovations.
3. Biotechnology & Biopharmaceuticals: Biologics, biosimilars, vaccines, and advanced biotechnological applications.
4. Pharmaceutical Chemistry & Analytical Sciences: Medicinal chemistry, drug analysis, quality control, and stability studies.
5. Clinical & Translational Research: Clinical trials, regulatory compliance, translational medicine, and personalized therapeutics.
6. Pharma Industry & Policy: Drug policy, regulatory affairs, pharmaceutical marketing, and healthcare economics.
7. Herbal & Natural Products: Phytopharmaceuticals, nutraceuticals, herbal formulations, and complementary medicine research.
8. Interdisciplinary Areas: Drug safety, pharmacovigilance, AI in drug development, and innovative pharma technologies.

Review Process and Publication Ethics – COPE Compliance (View Full Page)

IJPGARR strictly follows the ethical standards and best practices set by the Committee on Publication Ethics (COPE) to maintain academic integrity and transparency.

1. Peer Review: All manuscripts undergo a rigorous Double-Blind Peer Review process
2. Plagiarism Policy: Zero tolerance for plagiarism; all submissions are screened using professional plagiarism detection tools (Turnitin/iThenticate)
3. Transparency & Responsibility: Mandatory disclosure of conflicts of interest, ethical approvals, and clearly defined editorial and APC policies
4. Full Policy: Detailed guidelines are available on the Publication Ethics and Malpractice Statement page

Author & Editor Responsibilities

1. Clear authorship criteria and contributor transparency
2. Mandatory disclosure of conflicts of interest
3. Ethical handling of research data, references, and citations
4. Editorial independence, accountability, and fairness

Indexing & Visibility (View Full Page)

IJPGARR is committed to increasing the visibility and academic impact of published research. The journal is currently indexed and tracked in:

1. Google Scholar – Global discoverability and citation tracking
2. Crossref (DOI Registration) – Unique Digital Object Identifiers (DOIs) assigned to all published articles

Why Choose IJPGARR?

1. Creative Commons Licensing (CC BY 4.0) with full author copyright
2. International Editorial Board with expertise in pharmaceutical sciences and healthcare innovation
3. Rapid, fair, and transparent peer-review process
4. Global readership with unrestricted open access

Submission

Authors may submit their manuscripts via email at [email protected] or through the online submission system using this link: (Submit Manuscript)